Across rheumatic diseases

Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink

Rheumatology (Oxford)Published Cross-sectional and cohort studies

Authors' conclusion

IA analgesic prescribing of all classes is widespread.

Study context

Population
Patients with inflammatory arthritis (RA, PsA, axial spondyloarthritis (axSpA)) in England, CPRD Aurum, 2004–2020
Outcome
Annual prevalence of analgesic prescription
Methodological detailsClinical Practice Research Datalink Aurum, joinpoint regression, Cox proportional hazards models
  • Clinical Practice Research Datalink Aurum
  • Joinpoint regression
  • Cox proportional hazards models

Main finding

As reported in the abstract

Analgesic prescription prevalence in inflammatory arthritis (IA)

2004 prevalence, /100 person-years (PY)

84.2

95% CI 83.9, 84.5

2020 prevalence, /100 PY

64.5

95% CI 64.2, 64.8

Observational data: associations, not effects.

Further findings

NSAID prescription prevalence, 2004 (most prescribed; falling over time)

/100 PY
56.1 (95% CI 55.8, 56.5)

Opioid prescription prevalence, 2020 (most prescribed)

/100 PY
39.0
95% CI
38.7, 39.2

Gabapentinoid prescription prevalence (increased)

2004, /100 PY
1.1 (95% CI 1.0, 1.2)
2020, /100 PY
9.9 (95% CI 9.7, 10.0)

Chronic opioid prescription prevalence (most opioid prescriptions chronic) · 2020

/100 PY
23.4 (95% CI 23.2, 23.6)

Prescribing by subgroup

Non-NSAID analgesic prescribing commoner in RA, older people, females and deprived areas/northern England
NSAID prescribing commoner in axSpA/males, varying little by deprivation/geography

Prognostic factors for chronic prescriptions

Peri-diagnosis high-risk for starting chronic opioid/NSAID prescriptions
NSAIDs no consistently significant association with deprivation (unlike opioids/gabapentinoids)

Original publication

Analgesic prescribing in patients with inflammatory arthritis in England: observational studies in the Clinical Practice Research Datalink. Rheumatology (Oxford). Published 7 September 2023. doi:10.1093/rheumatology/kead463

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.